Abstract:Pulmonary vascular remodeling and fibrosis are the critical pathological characteristics of hypoxic pulmonary hypertension. Our previous study demonstrated that hypoxia is involved in the functional alteration of lung fibroblasts, but the underlying mechanism has yet to be fully elucidated. The aim of the present study was to investigate the effect of mast cells on the proliferation, function and phenotype of fibroblasts under hypoxic conditions. Hypoxia facilitated proliferation and the secretion of proinflammatory cytokines, including tumor necrosis factor (TNF)-alpha and interleukin (IL)-6, in human mast cells (HMC-1). RNA sequencing identified 2,077 upregulated and 2,418 downregulated mRNAs in human fetal lung fibroblasts (HFL-1) cultured in hypoxic conditioned medium from HMC-1 cells compared with normoxic controls, which are involved in various pathways, including extracellular matrix organization, cell proliferation and migration. Conditioned medium from hypoxic HMC-1 cells increased the proliferation and migration capacity of HFL-1 and triggered phenotypic transition from fibroblasts to myofibroblasts. A greater accumulation of collagen type I and III was also observed in an HFL-1 cell culture in hypoxic conditioned medium from HMC-1 cells, compared with HFL-1 cells cultured in normoxic control medium. The expression of matrix metalloproteinase (MMP)-9 and MMP-13 was upregulated in HFL-1 cells grown in hypoxic conditioned medium from HMC-1 cells. Similar pathological phenomena, including accumulation of mast cells, activated collagen metabolism and vascular remodeling, were observed in a hypoxic rat model. The results of the present study provide direct evidence that the multiple effects of the hypoxic microenvironment and mast cells on fibroblasts contribute to pulmonary vascular remodeling, and this process appears to be among the most important mechanisms underlying hypoxic pulmonary hypertension.

Novel hypoxia-induced HIF-1αactivation in asthma pathogenesis

Abstract 14566: the Role of Eosinophils in Pulmonary Hypertension

Regulation of hypoxia-inducible factor α in inflammation-associated diseases mediated by innate immune cells

Hypoxia-inducible factor 1 in autoimmune diseases.

LncRNA Hoxaas3 Promotes Lung Fibroblast Activation and Fibrosis by Targeting Mir-450B-5p to Regulate Runx1.

Hypoxia-inducible factor-1α and oral lichen planus

Function of pulmonary arterial fibroblasts in hypoxic pulmonary hypertension

Fas/FasL and Bronchial Asthma

Heme oxygenase-1 alleviates allergic airway inflammation by suppressing NF-κB-mediated pyroptosis of bronchial epithelial cells

The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance

Heme oxygenase-1 protects airway epithelium against apoptosis by targeting the proinflammatory NLRP3–RXR axis in asthma

Hypoxia-inducible factor 1-alpha is a driving mechanism linking chronic obstructive pulmonary disease to lung cancer

Oxygen sensors mediated HIF-1α accumulation and translocation: A pivotal mechanism of fine particles-exacerbated myocardial hypoxia injury

Hypoxic Mast Cells Accelerate the Proliferation, Collagen Accumulation and Phenotypic Alteration of Human Lung Fibroblasts

Neutrophil activation and NETosis are the predominant drivers of airway inflammation in an OVA/CFA/LPS induced murine model

Mutual inhibitory mechanisms between PPARγ and Hif-1α: implication in pulmonary hypertension.

Up-regulation of HSP90α in HDM-induced asthma causes pyroptosis of airway epithelial cells by activating the cGAS-STING-ER stress pathway

Oxygen homeostasis and cardiovascular disease: A role for HIF?

Hypoxia Inducible Factor-1Α is an Important Regulator of Macrophage Biology

Modeling the Regulation of P53 Activation by HIF‐1 Upon Hypoxia

Modeling the interplay between the HIF-1 and p53 pathways in hypoxia